RCCA oncologists outline pioneering approach to clinical trials for cancer patients
Share on facebook Share on twitter Share on linkedin Share on email Share on print Enabling people with cancer to participate in clinical trials without
Deciding whether or not to participate in a cancer clinical trial is a major healthcare decision. If you qualify, and your doctors recommend it, it’s up to you to decide if it is the best course of action. Before agreeing to participate, talk it over with your RCCA doctors, the researchers and your family and friends.
It’s important that you fully understand the study. Find out what the trial is hoping to achieve and research the drugs that you’ll be taking. Get a clear picture of what the procedure of the study will be and what will be expected of you. Some questions to ask might include:
Some cancer clinical trials require significant time, travel and money commitments. Depending on which one you choose, you might have to stay in the hospital, drive far distances or even relocate. Make sure the travel commitment is something feasible for you and your family. You’ll also likely have to attend many follow-up appointments and receive frequent tests and scans to see how your body is responding to the treatment.
There may be sponsors who cover some or all of the costs of cancer clinical trials. But, this is not always the case. Make sure you’re prepared to pay the costs and that your health insurance is willing to work with you.
Before consenting to a trial, make sure you have thoroughly considered all your options.
After collecting all this information and you feel confident about your decision, let your team know. No matter what path you choose to take, the doctors at RCCA will be there to help.
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Share on facebook Share on twitter Share on linkedin Share on email Share on print Enabling people with cancer to participate in clinical trials without
Hematologic cancer, or blood cancer, is one of the most common diagnoses treated at Regional Cancer Care Associates. Blood cancer refers to types like leukemia
Deciding whether to participate in a clinical trial can be difficult, even if your oncologist recommends it. Ultimately, it’s your decision, and that can feel
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.